Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

The current invention involves a series of fully recombinant multimerized forms of immunoglobulin Fc which thereby present polyvalent immunoglobulin Fc to immune cell receptors. The fusion proteins exist as both homodimeric and highly ordered multimeric fractions, termed stradomers. In comparison to...

Full description

Saved in:
Bibliographic Details
Main Authors Block, David S, Olsen, Henrik
Format Patent
LanguageEnglish
Published 10.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The current invention involves a series of fully recombinant multimerized forms of immunoglobulin Fc which thereby present polyvalent immunoglobulin Fc to immune cell receptors. The fusion proteins exist as both homodimeric and highly ordered multimeric fractions, termed stradomers. In comparison to the homodimeric fraction, purified multimeric stradomers have higher affinity and avidity for FcγRs with slower dissociation and are useful in the treatment and prevention of disease. The current invention demonstrates that directly linking IgG1 Fc regions to multimerization domains leads to enhanced multimerization and biological activity.
AbstractList The current invention involves a series of fully recombinant multimerized forms of immunoglobulin Fc which thereby present polyvalent immunoglobulin Fc to immune cell receptors. The fusion proteins exist as both homodimeric and highly ordered multimeric fractions, termed stradomers. In comparison to the homodimeric fraction, purified multimeric stradomers have higher affinity and avidity for FcγRs with slower dissociation and are useful in the treatment and prevention of disease. The current invention demonstrates that directly linking IgG1 Fc regions to multimerization domains leads to enhanced multimerization and biological activity.
Author Block, David S
Olsen, Henrik
Author_xml – fullname: Block, David S
– fullname: Olsen, Henrik
BookMark eNqNjTsOwjAQBV1Awe8OywGQIKRIDSKiB-rImE2w5N217HUBpycFoqZ6xczozc2EhXFmYluyF4aYRNFzBumBrZZkAzwL2R-BPtmBkDWDCriEVhEkPTCFF1AJ6gmTf-MDPFFhGYLcSxi71oETipK9jkd5aaa9DRlX312YdXu6Hs8bjNJhjtYho3a3y67aNnXdVIdq_4_zAXqRRqw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US12084482B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US12084482B23
IEDL.DBID EVB
IngestDate Fri Sep 27 05:30:55 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US12084482B23
Notes Application Number: US202117400367
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240910&DB=EPODOC&CC=US&NR=12084482B2
ParticipantIDs epo_espacenet_US12084482B2
PublicationCentury 2000
PublicationDate 20240910
PublicationDateYYYYMMDD 2024-09-10
PublicationDate_xml – month: 09
  year: 2024
  text: 20240910
  day: 10
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Gliknik Inc
RelatedCompanies_xml – name: Gliknik Inc
Score 3.5712705
Snippet The current invention involves a series of fully recombinant multimerized forms of immunoglobulin Fc which thereby present polyvalent immunoglobulin Fc to...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240910&DB=EPODOC&locale=&CC=US&NR=12084482B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1KFfWmVdH6wQiSWzBpkqYegpCkoQj9wLbSW9lNNlIpSWlTRH-9s0tivegtZGFJBmbfzO57bwHuHc6tWLhM75iWTQ1K6ug8NR51124LN-GMOUwKnPuDdm9qP8-cWQ3eKy2M8gn9UOaIlFEx5Xuh1uvVbhMrVNzKzQNf0Kv8KZp4oVZ2xwRPBH9a6Hvd0TAcBloQeNOxNnjxzJbRoU6k5dNyvSfLaOmz3331pSpl9RtSomPYH9FsWXECNZE14DCobl5rwEG_PPCmxzL3NqewirZyZwuVs8Ii22CeorLlZEtUN-1VI5iu2ZtSrmGRo6oKBSqLzeUnKgKhPKX5EgkupDgkl54gko-OUYySYV7RuM7gLupOgp5Onz7_idN8Ot79pXUO9SzPxAWgLRLXoshT4cbsNoGT0-GMCiXmxKlhxsklNP-ep_nf4BUcyZhL-oRpXEO9WG_FDWF0wW9VcL8BiAGaPw
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1KFetNq6L1awXJLZg0SVMPQUjSULVf2FZ6K7vJRiIlKW2K6K93dkmsF72FLCzJwOyb2X3vLcCtxZgRcpuqbd0wsUGJLZXF2r1qmy1uR4xSiwqBc3_Q6k7Np5k1q8B7qYWRPqEf0hwRMyrEfM_ler3cbmL5klu5vmMJvsoegonjK0V3jPCE8Kf4rtMZDf2hp3ieMx0rgxdHb2pt7ESaLi7XOza2hMJnv_PqClXK8jekBAewO8LZ0vwQKjytQ80rb16rw16_OPDGxyL31kewDDZiZ4tIZ4UkXZMsJtKWky6IvGmvHCHxir5J5RrJMyKrQk6kxebik0gCoTil-eIRSYQ4JBOeIIKPToKQCIZ5SeM6hpugM_G6Kn76_CdO8-l4-5fGCVTTLOWnQEwe2QZGHgs3arYQnKw2o1goUSuMNT2MzqDx9zyN_wavodad9Hvz3uPg-Rz2RfwFlULXLqCarzb8EvE6Z1cy0N_lkp0q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Fusion+proteins+of+natural+human+protein+fragments+to+create+orderly+multimerized+immunoglobulin+Fc+compositions&rft.inventor=Block%2C+David+S&rft.inventor=Olsen%2C+Henrik&rft.date=2024-09-10&rft.externalDBID=B2&rft.externalDocID=US12084482B2